Home » Topics » BioWorld Science

BioWorld Science
RSS

Guidant and Neuroperfusion to further develop device for stroke

April 30, 1997

Potent, selective and orally active COX-2 inhibitors from Parke-Davis

April 30, 1997

Roche discloses human renin inhibitors

April 30, 1997

GABA-B antagonists from Novartis

April 30, 1997

Kissei prepares smooth muscle cell proliferation inhibitors

April 30, 1997

Novel cardiac antiischemic agents disclosed by Kanebo

April 30, 1997

Endothelin antagonists reported by Kowa

April 30, 1997

ISIS-5320: preclinical study results

April 30, 1997

BMS-200475: profile of a novel anti-hepatitis B compound

April 30, 1997

Didox/Trimidox demonstrate antiretroviral activity in murine model

April 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...